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Purpose: SPARC (secreted protein, acidic, and rich in cysteine) is involved in extracellular matrix (ECM) organization.
The purpose of this study was to evaluate the expression of SPARC in iris tissue from primary angle closure glaucoma
(PACG) eyes.
Methods: Iris tissue was obtained from peripheral iridectomies performed during trabeculectomy surgery in nine PACG
and 16 primary open-angle glaucoma (POAG) eyes at the Singapore National Eye Centre. Three non-glaucoma control
iris specimens were obtained from patients who underwent Descemet’s stripping automated endothelial keratoplasty
(DSAEK) procedure. SPARC and collagen I expression were quantified by real-time polymerase chain reaction (PCR).
The histological distribution of collagen I and III in the iris stroma was determined using picrosirius red polarization.
Density of the iris stromal vasculature was also calculated.
Results: The mean age was 68.9±10.9 years and 65.7±12.2 years in POAG and PACG groups, respectively. The PACG
iris expressed SPARC 13.6-fold more and collagen I 5.2 fold more compared to non-glaucoma control iris. The PACG
iris also demonstrated 3.3 fold higher SPARC and 2.0 fold higher collagen I expression relative to the POAG iris. The
density of collagen I was greater in PACG eyes than in POAG and control eyes (p<0.001). The mean density of iris stromal
blood vessels per micron square area was similar in all three groups.
Conclusions: SPARC was significantly increased in the PACG iris. The data suggest that SPARC could play a role in
the development of PACG by influencing the biomechanical properties of the iris through a change in ECM organization.
Primary angle closure glaucoma (PACG) is a major form
of glaucoma in Asia [1]. The condition is visually destructive
and has been estimated to cause more blindness than primary
open-angle  glaucoma  (POAG)  worldwide  [2].  Several
anatomic risk factors for the development of PACG have been
identified including a shallow anterior chamber depth and
short axial length. Simulated model systems have provided
evidence that the presence of both increased lens curvature
and a short zonule-iris distance contribute to a pupil block in
angle closure [3]. Furthermore, both anteriorly located ciliary
bodies [4] predispose to non-pupillary block mechanisms in
angle closure. One of the anatomic changes that define PACG
is  the  formation  of  peripheral  anterior  synechiae  (PAS).
Synechial angle closure occurs in some but not all eyes with
PACG, and it is not clear why only some but not all eyes with
narrow ‘occludable’ angles go on to develop PACG. One
possibility is that the iris is biologically different in PACG
eyes,  and  this  structural  difference  plays  a  role  in  the
pathogenesis of PACG.
Previous studies have demonstrated the presence and the
relative compositions of collagens I and III in normal iris
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stroma [5,6]. In PACG eyes, an overall increase in collagen
deposition as well as an increase in collagen I relative to
collagen III deposition have been reported [7]. An increased
inflammatory cellular aggregation in the iris has also been
described following acute angle closure attack, which is likely
to further contribute to the observed increased collagen I in
PACG irides [7].
SPARC (secreted protein, acidic, and rich in cysteine) is
a  highly  evolutionarily  conserved  prototypic  32  kDa
matricellular  glycoprotein  that  is  centrally  involved  in
extracellular  matrix  (ECM)  remodeling  [8].  SPARC
expression is increased during embryogenesis, tissue injury,
and tissue repair [9,10]. SPARC features prominently in the
development of tissue fibrosis with subsequent loss of organ
function  such  as  in  the  liver,  lungs,  kidneys,  and  skin
[11-14].  SPARC  therefore  plays  an  important  role  in  the
development of diseased states. This is corroborated by the
creation  of  SPARC  null  mice,  which  displayed  several
phenotypic  abnormalities  associated  with  aberrant  ECM
structure and assembly [10,15,16]. In particular, adult SPARC
null mice exhibited decreased amounts of collagen in the skin
and bone [17,18], and fibrotic deposition of collagen was
diminished in the absence of SPARC [10]. Hence, increased
expression of SPARC is associated with collagen I production
while  the  lack  of  SPARC  results  in  decreased  collagen
accumulation. All these data strongly implicate SPARC as a
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1886key regulator of collagen incorporation in tissues. In fact,
SPARC has long been considered a chaperone for promoting
collagen folding, secretion, maturation, and assembly into
macromolecules in the ECM [19,20].
In the eye, SPARC expression has been detected in retina
ganglion  cells  and  astrocytes  where  it  serves  to  maintain
retinal  function  [18-21]  in  the  trabecular  meshwork  [22].
SPARC also has a role in the development of cataract and
posterior capsule opacification [23,24]. However, we are still
unaware of previous research on SPARC expression in the
iris,  particularly  in  relation  to  PACG.  In  view  of  the
established  role  of  SPARC  in  the  promotion  of  fibrotic
collagen  I  deposition  as  well  as  the  observed  increased
expression of collagen I previously reported in PACG iris, we
performed experiments to evaluate the expression of SPARC
in the PACG iris. In addition, we compared the density of iris
stromal vascularity to determine whether blood vessel density
contributes to observed features in PACG iris ultrastructure.
METHODS
Study population: This study was conducted in accordance
with the Declaration of Helsinki and after approval from the
local institutional review and ethics board at the Singapore
Eye Research Institute (SERI). Eligible subjects with poorly
controlled PACG or primary open-angle glaucoma (POAG)
undergoing  trabeculectomy  surgery  were  recruited  at  the
Singapore National Eye Centre (SNEC) over a six-month
period.  An  informed  written  consent  pertaining  to  the
donation and storage of human tissue was obtained from all
subjects.
POAG and PACG were diagnosed in the presence of
glaucomatous  optic  nerve  head  damage  (defined  by  the
presence of neuroretinal rim loss of the optic nerve head and
vertical cup-disc ratio of 0.7 or greater) with corresponding
visual field loss. Eyes with PACG had gonioscopic findings
of angle closure (present when the trabecular meshwork was
not  visualized  in  at  least  two  quadrants  on  indentation
gonioscopy  with  the  presence  of  PAS).  Trabeculectomy
surgery was indicated in the presence of poorly controlled
glaucoma where there was suboptimal intraocular pressure
(IOP) control despite maximal compliant medical therapy
and/or progressive visual field loss and optic disc cupping. A
combined trabeculectomy and cataract surgery was performed
in  some  cases  where  clinically  indicated.  Relevant
preoperative  data  collected  includeed  age,  gender,  race,
glaucoma type, history of acute angle closure attacks (if any),
prior laser iridotomy or iridoplasty, preoperative IOP, and
glaucoma medications.
Non-glaucomatous  control  subjects  comprised  of
patients  undergoing  Descemet’s  stripping  automated
endothelial  keratoplasty  (DSAEK)  procedure  for  the
management of corneal endothelial decompensation, which is
secondary to Fuchs endothelial dystrophy. Patients with pre-
existing glaucoma or those with corneal decompensation as a
result of intraocular inflammation were excluded.
Iris  specimen  collection:  The  iris  tissue  specimens  were
obtained from peripheral iridectomies performed as part of a
standard  trabeculectomy  and  DSAEK  procedure.
Intraoperatively, the peripheral iridectomies were performed
in the superior peripheral iris between 10 and 2 o’clock. Each
iris  tissue  specimen  obtained  was  fixed  in  a  test  tube
containing  3%  paraformaldehyde  and  subsequently
embedded  in  paraffin  wax.  All  specimens  were  cut  for
histological  staining  and  reverse  transcriptase  polymerase
chain reaction (RT–PCR) analysis.
Polarization microscopy using Sirius red stain: Iris samples
were stained with picrosirius red F3BA (Sigma Sirius Red;
Sigma,  Steinheim,  Germany)  stain.  Qualification  of  the
amount  of  collagen  I  present  using  polarized  light  was
performed using a grading system of 1–4, which estimated the
percentage of the section that was stained red: grade 1 (25%
or less), grade 2 (25%–50%), grade 3 (50%–75%), and grade
4 (75%–100%). Due to the subjectivity of the grading, each
section  was  graded  by  two  masked  independent  medical
personnel   (T.T.W.  and   A.C.)  where   inter-observer
variability  was  assessed.  To  ascertain  the  validity  of  our
findings,  real-time  RT–PCR  was  performed  on  all  the
specimens to provide a quantitative analysis, which would
support the histopathological assessment.
Density analysis of iris stromal vasculature: The paraffin
sections were stained with hematoxylin and eosin (H&E) and
examined using light microscopy. For each iris section, the
number  of  blood  vessels  was  counted  manually  at  10X
magnification, and the cross-sectional area was calculated
using an Image J Image Processing and Analysis in Java
version 1.40 (NIH Image, Research Services Branch, National
Institutes  of  Health,  Bethesda,  MD).  The  density  of  iris
stromal vascularity was derived from the quotient of total
number of blood vessels over total cross-sectional area of iris.
Quantitative  real-time  polymerase  chain  reaction:
Quantification  of  SPARC  and  collagen  I  expression  was
performed using real-time RT–PCR. Total mRNA from each
group was extracted and purified using the High Pure RNA
Paraffin Kit (Roche, Mannheim, Germany) according to the
manufacturer’s protocol. cDNA was then synthesized using
SuperScript III (Invitrogen, Carlsbad, CA). This was followed
by PCR amplification with Power SYBR Green PCR Master
Mix  (Applied  Biosystems,  Warrington,  UK).  The  cycling
conditions were as follows; denaturation at 95 °C for 10 min
followed by 40 cycles at 95 °C for 15 s, 50 °C for 2 min, and
60 °C for 1 min in a LightCycler 480 (Roche). The fluorescent
threshold  was  calculated  using  the  system  software,  and
results  analyzed  using  the  comparative  cycle  threshold
method. Collagen I was amplified with the following primers:
(forward)  5′-CAG  CCG  CTT  CAC  CTA  CAG  C-3′  and
(reverse) 5′-TTT TGT ATT CAA TCA CTG TCT TGC C-3′.
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5′-GTG CAG AGG AAA CCG AAG AG-3′ and (reverse) 5′-
TGT TTG CAG TGG TGG TTC TG-3′. Normalization was
done  for  each  sample  against  similarly  amplified  β-actin:
(forward)  5′-CCA  ACC  GCG  AGA  AGA  TGA-3′  and
(reverse) 5′-CCA GAG GCG TAC AGG GAT AG-3′.
Statistical  analysis:  Statistical  analysis  of  continuous
variables  was  performed  using  non-parametric  Mann–
Whitney U test while categorical variables were analyzed
using the Student’s t-test. A Bland Altman statistical test was
used to evaluate for any significant inter-observer variability.
A  p  value  less  than  0.05  was  considered  statistically
significant.
RESULTS
Patient demographic and preoperative data: Twenty-eight
subjects were recruited in this study, and the recruits were
composed of nine PACG patients, 16 POAG patients, and
three non-glaucoma controls. The demographics and relevant
clinical details of the glaucoma subjects are shown in Table
1. The mean ages of the POAG and PACG  groups were
68.9±10.9 and 65.7±12.2 years, respectively, and the majority
of subjects were Chinese (PACG 89% and POAG 88%). The
mean number of medications used in both PACG and POAG
groups were comparable with the use of topical prostaglandin
analogs in 56% of patients in both glaucoma groups. The mean
preoperative IOP in the POAG group was 21.7±6.6mmHg and
17.6 ± 3.7 mmHg in the PACG group. The mean vertical cup-
disc ratios in the POAG and PACG groups were 0.9±0.07 and
0.8±0.2, respectively. Only two of the nine PACG eyes had a
previous history of an acute angle closure episode. All but one
eye  in  the  PACG  group  had  undergone  laser  peripheral
iridotomy before trabeculectomy. None of the PACG eyes
underwent laser iridoplasty.
mRNA expression of SPARC and collagen I in the iris: The
expression levels of SPARC and collagen I in PACG, POAG,
and non-glaucoma iris specimens were analyzed by real-time
RT–PCR. A higher level of SPARC expression in individual
iris specimens from PACG eyes compared to both POAG iris
specimens  and  non-glaucoma  controls  was  observed  as
represented by Ct values normalized against the respective β-
actin Ct values (∆Ct; Figure 1A). The expression of SPARC
was significantly higher in PACG iris specimens with a 3.3
fold and 13.6 fold higher expression than in POAG and non-
glaucoma iris specimens, respectively (Figure 1B). A higher
level of collagen I expression in individual iris specimens
from PACG eyes compared to both POAG iris specimens and
non-glaucoma controls was similarly observed (Figure 1C)
with PACG iris specimens expressing a mean 2.0 fold and 5.2
fold  more  collagen  I  than  POAG  and  non-glaucoma  iris
specimens, respectively (Figure 1D). These findings provide
supporting evidence of a positive relationship between the
expression levels of SPARC and collagen I. First, all the
PACG iris samples demonstrated a higher expression level of
SPARC and collagen I compared to both POAG and non-
glaucoma irides. Second, when examined across individual
samples, PACG iris specimen number 6 featured an unusually
high level of collagen I expression (Figure 1C) and was also
associated with a relatively high level of SPARC expression
(Figure 1A). Incidentally, specimen number 6 was not from
one of the acute angle closure attack eyes.
TABLE 1. DEMOGRAPHIC AND PREOPERATIVE DATA OF POAG AND PACG PATIENTS.
Glaucoma Type PACG (n=9) POAG (n=16) p value (2 sided)
Mean age in years (SD) 65.7 (12.2) 68.8 (10.9) 0.46
Gender 0.43
Male 5 6
Female 4 10
Race 1
Chinese 8 14
Malay 1 2
Indian 0 0
Others 0 0
Number of eyes with history of acute
angle closure
2 NA NA
Mean number of medications (SD) 1.89 (1.17) 1.95 (0.85) 0.93
Number of eyes using topical
prostaglandin analog (%)
5 (56%) 9 (56%) 1
Mean preoperative intraocular
pressure (SD)
17.6 (3.7) 21.7 (6.6) 0.09
Number of eyes with prior laser iridotomy 8 NA NA
Mean cup-to-disc ratio (SD) 0.8 (0.2) 0.9 (0.07) 0.09
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shows iris sections stained with picrosirius red stain obtained
from PACG, POAG, and non-glaucoma irides. The mean
grading for the PACG group was 3.89±0.33 while the mean
grading for the POAG group was 2.70±0.52. All three non-
glaucoma DSAEK iris specimens demonstrated a grading of
1, which corresponded to the iris grading from a normal fixed
eye specimen (data not shown). The difference among the
three groups was significant (p<0.001; Table 2) The Bland
Figure 1. SPARC and collagen I mRNA expression measured by
quantitative real-time RT–PCR. Total RNA was purified from the
iris stroma of PACG (n=9), POAG (n=16), and normal (n=3) subjects
and analyzed by real-time quantitative RT–PCR. A: SPARC mRNA
expression in PACG, POAG, and non-glaucomatous iris specimens
is shown in the chart. The y axis (ΔCt) represents SPARC expression
normalized  against  β-actin  expression.  The  data  revealed  an
overexpression of SPARC in the iris tissue from PACG and POAG
individuals relative to the iris tissue from non-glaucomatous subjects.
B: Fold expression of SPARC mRNA in PACG and POAG relative
to non-glaucomatous specimens is shown. The data illustrated on the
graph  represent  the  mean±SEM  of  fold  expression  (2-∆Ct,PACG/
∆Ct,POAG-∆Ct,normal) of SPARC in PACG and POAG specimens relative
to that in non-glaucomatous specimens (fold expression=1). The
PACG iris contained a mean 13.6 fold and a mean 3.3 fold more
SPARC  than  non-glaucomatous  and  POAG  iris  (p<0.001),
respectively. The POAG iris contained a mean 4.1 fold more SPARC
than non-glaucomatous iris. C: Collagen I mRNA expression in
PACG, POAG, and non-glaucomatous iris specimens is shown. The
y axis (ΔCt) represents collagen I expression normalized against β-
actin expression. The data revealed an overexpression of collagen I
in the iris from PACG and POAG individuals relative to the iris from
normal subjects. D: The fold expression of collagen I mRNA in
PACG and POAG relative to non-glaucomatous specimens is given
in the graph. The data illustrated on the graph represent the mean
±SEM of fold expression (2-∆Ct,PACG/∆Ct,POAG-∆Ct,normal) of collagen I
in PACG and POAG relative to that in non-glaucomatous specimens
(fold expression=1). The PACG iris contained a mean 5.2 fold and
a mean 2.0 fold more collagen I than non-glaucomatous and POAG
iris (p<0.001), respectively, and the POAG iris contained a mean 2.6
fold more collagen I than non-glaucomatous iris.
Altman test showed an excellent agreement of 96% between
the two masked independent observers (95% CI 95.9-96.3).
Iris stromal blood vessel density: The mean iris stromal blood
vessel density per square micron cross-sectional area in the
respective groups was as follows: 2.62×0−5±1.14 (PACG),
2.97×10−5±1.18 (POAG), and 1.99×10−5±0.39 (DSAEK, non-
glaucomatous iris). There was no significant difference in the
density of stromal blood vessels between PACG and POAG,
PACG and Control, and POAG and Control groups (Table 3).
DISCUSSION
SPARC is a matricellular protein that is secreted by several
cell types such as fibroblasts, endothelial cells, and epithelial
cells  during  an  inflammatory  response,  tissue  reparative
process, and matrix remodeling [25]. One of the principal
functions  of  SPARC  is  the  regulation  of  collagen  I
incorporation  into  tissues.  It  does  so  by  binding  to  ECM
proteins including collagens I, III, and IV [8], stimulating
collagen I production, and cross-linking collagen fibrils to
increase  tensile  strength  [19].  This  has  been  clearly
demonstrated in the skin of SPARC null-mice, which has been
shown to be considerably more fragile than in their wild-type
counterparts. Ultrastructural analysis has also revealed that
the collagen I fibrils are smaller in diameter in the null species
than in wild-type animals [16].
In  this  study,  we  found  a  significant  increase  in  the
expression  of  SPARC  in  the  iris  tissue  of  PACG  eyes
compared  to  POAG  and  non-glaucoma  eyes.  We  also
observed a corresponding increase in collagen I deposition in
PACG iris. This histological finding of increased deposition
of mature collagen I not only concurred with a previous study
[7] but also further reinforced the established role of SPARC
as a modulator of collagen I production. The marked increase
in SPARC, which was detected histologically together with
the mRNA data in PACG iris, indicated the presence of a
possible  ongoing  reparative  process  and/or  stress
environment.  Furthermore,  the  effect  of  laser  peripheral
iridotomy on PACG eyes would exert a local inflammatory
effect and account for the observed differences in SPARC and
collagen expression between PACG and POAG eyes.
Acute angle closure attacks have been shown to result in
significant inflammatory changes to the iris tissue [8], the
stress of which could lead to a corresponding increase in
SPARC  expression  and  subsequent  increase  in  collagen  I
cross-linking and reorganization. Interestingly, the majority
of PACG eyes in our study did not have any prior history of
acute angle closure attacks, particularly PACG patient number
6, whose iris tissue demonstrated the greatest expression of
SPARC and collagen I. One possibility for this is that chronic
angle closure with PAS or sub-acute angle closure episodes
over a period of time may account for the high SPARC levels
found in patient number 6. Furthermore, this also suggests that
the increased collagen deposition in PACG eyes cannot be
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alone.
Collagens  I  and  III  form  the  majority  of  the  ECM
component in the iris stroma [5] with collagen I providing
tissue structure and strength. An increase in the content and
structural organization of collagen I leads to changes in tissue
rigidity. A change in iris rigidity has important influence on
its biomechanics, and therefore, iris ECM composition would
play an important role in the development of angle closure
mechanisms [7]. Furthermore, the development of PAS seen
in PACG eyes may be associated in part to the change in the
composition of collagen components in the iris ECM, which
has been previously reported by He et al. [7]. The authors
suggested that the development of PACG might have arisen
from a difference in the ratio of collagen I and III composition,
which ultimately led to a change in the mechanical response
of the tissue and the dynamic relationship between the iris and
the  trabecular  meshwork.  In  the  presence  of  a  narrow  or
occludable angle, it is reasonable to suggest that changes in
the  framework  of  the  iris  ECM  may  have  a  role  in  the
development of PAS and therefore PACG.
An  unexpected  finding  in  this  study  was  the  notable
increase of SPARC in POAG iris (but to a lesser degree than
that seen in PACG iris). Chronic use of topical medications,
which is often the case with glaucoma patients, potentially
leads to a subclinical inflammatory state [26] as a result of the
presence of the preservative, benzalkonium chloride, which is
known  to  generate  a  pro-inflammatory  cellular  profile
[27-29].  Topical  prostaglandin  analogs  have  also  been
reported  to  disrupt  the  blood-aqueous  barrier  [30],  hence
giving rise to a persistent mild anterior uveitis [31,32]. In both
POAG and PACG groups, a comparable mean number of
topical  glaucoma  medications  were  used,  and  a  similar
proportion of patients were on prostaglandin analogs. This
pro-inflammatory state induced by prolonged use of topical
medications is likely to account for an elevation of SPARC
Figure 2. Analysis of iris sections by Sirius red staining. Iris sections from PACG (A), POAG (B) as well as normal (C) patients were stained
with Picrosirius red. When viewed with a polarized light, mature type I collagen fibers appear bright yellow or orange. Magnification x20.
TABLE 2. HISTOLOGICAL GRADING OF PICROSIRIUS RED STAINING IN IRIS SAMPLES.
Group n Median grading Mean grading Standard deviation Mann–Whitney U 2-sided
PACG 9 4 3.89 0.33 <0.001
POAG 16 2 2.7 0.52 <0.001
DSAEK 3 1 1 0 <0.001
The differences in the mean grade between PACG and POAG, PACG and Control, and POAG and Control were significant
(p<0.001). n denotes the number of patients in each group.
TABLE 3. COMPARISON OF MEAN STROMAL BLOOD VESSEL DENSITY BETWEEN PACG AND POAG, PACG AND NON-GLAUCOMA, AND POAG
AND NON-GLAUCOMA GROUPS.
Groups n mean (SD) Mann–Whitney U p value
Mean density PACG 9 2.62 (1.14) 0.50
POAG 16 2.97 (1.18) 0.50
Mean density PACG 9 2.62 (1.14) 0.41
Control 3 1.99 (0.39) 0.41
Mean density POAG 16 2.97 (1.18) 0.15
Control 3 1.99 (0.39) 0.15
There was no significant difference in the density of stromal blood vessels between any of the groups compared.
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significantly greater expression of SPARC in the PACG iris
compared to the POAG iris is likely secondary to other factors,
which are yet to be determined. Further studies would be
necessary to validate our findings.
To  determine  whether  a  difference  in  iris  stroma
vascularity could be an additional contributory factor for the
ultrastructural  differences  and  therefore  alteration  in  the
biomechanical  properties  of  the  PACG,  POAG,  and  non-
glaucoma iris, we devised a simple method to calculate the
number of blood vessels and the total surface area of the iris
cross-section. Our results showed that there was no difference
in the mean density of iris stromal vascularity between PACG,
POAG, and non-glaucoma eyes. However, our method of
evaluation  was  subject  to  several  limitations.  First,  the
sampled  cross-sectional  area  of  the  iris  varied  with  each
specimen. The area of each cross-section is dependent upon
the  size  of  the  tissue  obtained  during  each  peripheral
iridectomy  as  well  as  on  the  tissue  orientation  during
embedding within paraffin blocks. This issue is exacerbated
by the fact that the iridectomy was only a small sampling of
the entire iris and that the blood vessels were not likely to be
evenly distributed throughout the stroma, hence the larger the
area of iris section, the greater probability of blood vessels
seen. Second, the apparent number of blood vessel lumen
counted in each iris section might have been different cross-
sections of the same vessel. Again, this is dependent on both
the orientation of the iris tissue during sectioning as well as
the inherent orientation of the blood vessels within the stroma,
both  of  which  would  be  difficult  to  control  across  all
specimens.
A limitation to the study was the control iris used for
comparison.  It  is  unproven  whether  iris  from  Fuchs  eyes
would be entirely free from iris damage. However, careful
patient selection was conducted to only retrieve iris from
patients  undergoing  DSAEK  with  a  diagnosis  of  Fuchs
without any previous history of intraocular surgery or a history
of  glaucoma.  The  use  of  iris  taken  from  peripheral
iridectomies from patients without any other ocular pathology
who undergo routine cataract surgery with anterior chamber
lens implantation would have been the preferable control, but
the number of these patients in the Department is extremely
low.
In conclusion, we are the first to demonstrate an increase
in SPARC expression in the iris of PACG eyes. POAG eyes
also showed elevated SPARC levels albeit to a lesser degree
than  that  observed  in  PACG  eyes.  The  significance  of
increased  SPARC  expression  in  POAG  eyes  is  yet  to  be
determined. However, in PACG, we propose that SPARC
through  its  effect  on  iris  ECM  composition  is  likely  to
contribute to changes in iris biomechanics that define angle
closure glaucoma. Further work is now necessary to test this
hypothesis.
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